AUS
NZ
UK
CA
USA
IND
Healthcare
Is CSL (ASX:CSL) Turning the Corner as Healthcare Heals?
July 21, 2026 04:11 PM AEST| By SamThe blood-products heavyweight steadied and pushed higher as the Australian healthcare sector rebounded sharply from a multi-year low. After a punishing year that left the name deeply out of favour, the bounce hinted that the worst of the sector's gl...
Can ResMed (ASX:RMD) Reignite Growth by Slimming Down?
July 21, 2026 04:10 PM AEST| By SamThe sleep and breathing-health specialist agreed to divest a non-core software arm, streamlining itself around its highest-growth ambitions. The move landed as healthcare names clawed back ground from steep lows, giving the cleaner strategy extra roo...
What Rattled Cochlear (ASX:COH) and ASX Healthcare?
July 21, 2026 04:10 PM AEST| By SamThe hearing-implant leader stunned the market by slashing its profit outlook for the year, citing softer demand and shipment disruption tied to conflict overseas. The downgrade rippled across a healthcare sector whose mood was already fragile after a...
After a Remarkable Year, Racura Oncology (ASX:RAC) Adds Another Gain
July 21, 2026 07:45 AM AEST| By Sonal GoyalRacura Oncology Ltd (ASX:RAC) closed higher on 21 July 2026, with its shares gaining 2.00% to finish at AUD 2.04. The latest advance adds to an already strong longer-term performance, with the stock remaining 77.39% higher over the past year.
CSL rebounds as ASX healthcare finds a pulse
July 21, 2026 04:06 PM AEST| By SamCSL shares steadied as the ASX healthcare sector rebounded sharply from a multi-year low. A bruising year of downgrades and writedowns had left the blood-products major deeply out of favour before the bounce.
Why did Cochlear's downgrade rattle ASX healthcare?
July 21, 2026 04:06 PM AEST| By SamCochlear stunned the market by slashing its profit outlook, citing softer demand and shipment disruption. The downgrade rippled across an ASX healthcare sector still nursing a fragile mood after a difficult year.
ResMed sharpens focus with a strategic sale: The Shift Few Are Watching
July 21, 2026 04:06 PM AEST| By SamResMed agreed to divest a non-core software business to sharpen its focus on sleep and breathing health. The move, part of a longer-term growth plan, landed as ASX healthcare names clawed back ground from steep lows.
Australian Clinical Labs (ASX:ACL) Stock Edges Lower as Investors Assess the Healthcare Sector
July 21, 2026 07:44 AM AEST| By Sonal GoyalAustralian Clinical Labs Ltd (ASX: ACL) was trading at AUD 2.31, down 0.86% (AUD 0.020) during the afternoon trading session on 21 July 2026. Despite the day's decline, it is important to recognise that a single trading session does not necessarily reflect a company's …
Why Is Telix (ASX:TLX) Facing a Radiopharma Proof Test?
July 21, 2026 03:10 PM AEST| By SamTelix faces a radiopharma proof test as imaging adoption, regulatory progress, manufacturing reliability, reimbursement access and cash discipline shape confidence in its commercial healthcare platform.
CSL (ASX:CSL): Why Is Healthcare Confidence Returning?
July 21, 2026 03:09 PM AEST| By SamCSL remains in focus as margin recovery, product mix, plasma efficiency and disciplined execution shape confidence in the company and Australia’s broader healthcare sector during a selective market environment.
Why Is Pro Medicus (ASX:PME) Still in the Imaging Spotlight?
July 21, 2026 03:09 PM AEST| By SamPro Medicus remains in focus as contract execution, clinical workflow, hospital demand, recurring software use and disciplined expansion shape Australia’s healthcare technology discussion through a selective market cycle.
Oceania Healthcare (ASX:OCA) Trades Lower: Key Factors Healthcare Investors Typically Monitor
July 21, 2026 06:45 AM AEST| By Sonal GoyalThe share price of Oceania Healthcare Ltd (ASX:OCA) declined 0.81% to AUD 0.61 during the afternoon trading session on 21 July 2026. While short-term market movements often capture investor attention, experienced market participants generally assess daily price changes alongside the company's long-term operating performance, …
PYC Therapeutics (ASX:PYC) Appoints New CFO as Investors Watch Clinical and Funding Progress
July 21, 2026 10:08 AM AEST| By SamPYC Therapeutics has strengthened its executive leadership through the appointment of an experienced biotechnology finance executive as the company continues advancing its RNA-based clinical programs.
ASX Healthcare Shares Extend Their Rebound Off A Low Base
July 20, 2026 05:35 PM AEST| By SamThe ASX healthcare sector has rebounded sharply off a multi-year low, led by plasma and sleep-device names, with the market awaiting results season to test whether earnings support the recovery.
Does Cochlear's (ASX:COH) Bounce Have Room After A Deep Fall?
July 20, 2026 05:35 PM AEST| By SamCochlear shares have bounced as broader ASX healthcare sentiment steadied, reviving debate over whether the recovery in the premium-rated hearing-implant maker has further room after a deep slide.
Telix Pharmaceuticals (ASX: TLX) Gains as Revenue Growth Keeps FY2026 Guidance on Track
July 21, 2026 04:31 AM AEST| By Aditi SarkarTelix Pharmaceuticals Limited (ASX: TLX) traded higher during intraday dealings on 21 July 2026 after releasing its second-quarter business update. Investors responded to continued revenue growth, with the company reporting stronger sales across its commercial imaging portfolio while maintaining its full-year revenue guidance. The …
Why Is Pro Medicus (ASX:PME) Turning Heads Right Now?
July 20, 2026 05:35 PM AEST| By SamSpecialist ASX healthcare names in medical imaging software and radiopharmaceuticals have held the spotlight as clinical and commercial milestones fuel interest, with the market weighing rich valuations against long growth runways.
Why Is Ramsay Health Care (ASX:RHC) Testing ASX 200 Confidence?
July 20, 2026 05:30 PM AEST| By SamRamsay Health Care remains in focus as hospital utilisation, labour discipline, funding quality and cash conversion shape confidence in its margin recovery and broader operating reset across healthcare markets.
Why Is Cochlear (ASX:COH) Back in Healthcare Focus?
July 20, 2026 05:29 PM AEST| By SamCochlear remains in focus as implant procedures, margin discipline, global patient demand and cash conversion shape the Australian market’s assessment of healthcare operating quality and resilience today.
_07_21_2026_04_25_45_992858.jpg)
PYC Therapeutics (ASX: PYC) Eases as Investors Track Clinical Pipeline Progress
July 21, 2026 04:25 AM AEST| By Aditi SarkarPYC Therapeutics Limited (ASX: PYC) traded lower during intraday trading on 21 July 2026 as investors continued assessing clinical-stage biotechnology companies amid broader market volatility. The decline occurred without any confirmed company-specific announcement, with the movement appearing consistent with the day-to-day fluctuations often seen …
Why Is ResMed (ASX:RMD) Back in Healthcare Focus?
July 20, 2026 05:29 PM AEST| By SamResMed remains in focus as sleep device demand, recurring mask revenue, connected health adoption, margin discipline and cash conversion shape the Australian market’s assessment of healthcare operating quality.
Imricor (ASX:IMR) Moves Closer to Full US FDA Platform
July 20, 2026 11:11 AM AEST| By SamImricor has advanced its US regulatory program, shifting investor attention toward hospital adoption and commercial expansion of its MRI-guided cardiac platform.
Why Are Flight Centre (ASX:FLT), Macquarie Technology (ASX:MAQ) and Mesoblast (ASX:MSB) Drawing Long-Term Attention?
July 20, 2026 09:54 AM AEST| By SamFlight Centre, Macquarie Technology Group and Mesoblast remain in focus as long-term business strategies, technology investment and healthcare innovation continue shaping their respective industries.
Saluda Medical (ASX: SLD) Declines as Investors Monitor US Commercial Expansion
July 21, 2026 04:24 AM AEST| By Aditi SarkarSaluda Medical, Inc. (ASX: SLD) traded lower during intraday dealings on 21 July 2026 as investors continued assessing recently listed healthcare companies. The decline occurred without any confirmed company-specific announcement, with broader weakness across emerging medical technology stocks appearing to influence trading sentiment. The …
Why Is Summerset Group (ASX:SNZ) Expanding Its Share Capital?
July 20, 2026 09:41 AM AEST| By SamSummerset Group has issued additional ordinary shares under its employee incentive programme, highlighting its continued focus on employee participation, long-term alignment and capital management.
Are Amcor (ASX:AMC) and Sonic Healthcare (ASX:SHL) Trading Below Their Historical Valuations?
July 20, 2026 09:35 AM AEST| By SamAmcor and Sonic Healthcare are trading below selected historical valuation measures, bringing their dividend profiles, revenue multiples, cash generation and operational performance into focus.
Advertise your brand on Kalkine Media